April 3 (Reuters) - Pfizer Inc is in talks with Procter & Gamble Co <P&G.N> for a sale of the U.S. drugmaker's consumer health business, CNBC reported on Tuesday, citing sources.
Pfizer is considering options with P&G, including a joint venture, according to the report, adding that the companies were far apart on a price for the business.
Pfizer and P&G could not be immediately reached for comment.
GlaxoSmithKline, Reckitt Benckiser and Johnson & Johnson have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion
(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)